CVS

Historical Earnings Reliability and Post-Report Drift

CVS Health has delivered earnings per share ahead of the consensus estimate in 7 of its last 8 reported quarters, an 88% beat rate, with an average earnings surprise of 14%. That consistency is paired with a directional tendency: the average 5-day price move in the five trading days after those reports is 3.9%, classified as an "up" drift. The pattern, however, is not uniform across the most recent four reports. On May 6, 2026, CVS reported actual EPS of $2.57 against an estimate of $2.18, a 17.9% beat, yet the stock rose just 0.58% the next day before extending to a 12.95% gain over the following five days. The February 10, 2026 release, with actual EPS of $1.09 versus estimate $1.00, a 9% surprise, saw a 1.85% next-day gain and a 2.82% five-day advance. By contrast, the October 29, 2025 report produced a 16.8% beat—actual EPS $1.60 versus estimate $1.37—but the stock fell 4.85% the next day and was down 2.54% over the next five sessions. The July 31, 2025 report, the largest beat in this window, delivered actual EPS of $1.81 versus an estimate of $1.46, a 24% surprise, with the stock up 0.6% the next day and 2.38% over five days. Those divergences show that beating estimates has historically been the baseline, but the market's reaction function depends on what else accompanies the headline number.

Options-Flow Dynamics Around the August 5 Report

CVS is scheduled to report next on August 5, 2026, before the market open, with a consensus EPS estimate of $1.86. With the stock at $104.43, an RSI of 49.0, and the 50-day EMA at $100.94, the setup sits near neutral momentum but above its medium-term moving average. Heading into the report, options-market activity reflects positioning for the 14% average earnings surprise and the 3.9% average five-day drift. Watch whether call or put open interest builds more aggressively into the print, because the flow can reveal where the market's real expectation sits relative to the published consensus. A skew toward one direction may indicate that traders are pricing in a gap scenario rather than a muted response, a distinction reinforced by the last four reports, in which five-day moves of 12.95%, 2.82%, -2.54%, and 2.38% diverged from next-day moves of 0.58%, 1.85%, -4.85%, and 0.6%.

What a Disciplined Trader Watches

Because CVS has beaten in 88% of the last eight quarters but still produced a five-day decline after one of those beats—the October 29, 2025 report—a disciplined trader separates the earnings outcome from the price reaction. The data show next-day moves of 0.58%, 1.85%, -4.85%, and 0.6% across the last four reports, while five-day moves were 12.95%, 2.82%, -2.54%, and 2.38%. That spread implies that short-term volatility around the report is normal and that holding through subsequent sessions has been more decisive than the opening gap alone. With the 50-day EMA at $100.94 and price at $104.43, proximity to that average can also matter: a post-earnings move may test whether the EMA acts as support or is violated. A disciplined trader tracks pre-report volume, options implied volatility expansion, and whether post-report price action confirms or rejects the $100.94-$104.43 zone.

To dig deeper into how sell-side analysts, institutional positioning, and risk models are interpreting these same metrics, explore the full institutional verdict for CVS on our platform.